MARKET

VCRE

VCRE

Vicore Pharma Hldg AB
NASDAQ
10.22
+0.10
+0.99%
Opening 09:35 11/18 EST
OPEN
10.20
PREV CLOSE
10.12
HIGH
10.22
LOW
10.20
VOLUME
1.43K
TURNOVER
--
52 WEEK HIGH
17.80
52 WEEK LOW
7.88
MARKET CAP
287.72M
P/E (TTM)
-54.6816
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VCRE last week (1109-1113)?
Weekly Report · 2d ago
Weekly Report: what happened at VCRE last week (1102-1106)?
Weekly Report · 11/09 10:34
Guggenheim Sticks to Their Buy Rating for Vicore Pharma Holding AB (6Y4)
TipRanks · 11/06 15:15
Vicore Pharma Holding AB (publ) Q3 GAAP EPS of SEK -$0.44, revenue of SEK 0.6M
Seeking Alpha · 11/05 17:20
Nike downgraded, Circle Internet upgraded: Wall Street’s top analyst calls
TipRanks · 11/05 15:01
Chardan Capital Initiates Coverage On Vicore Pharma Holding with Buy Rating, Announces Price Target of $15
Benzinga · 11/05 00:26
Vicore Pharma initiated with a Buy at Chardan
TipRanks · 11/04 22:55
Weekly Report: what happened at VCRE last week (1026-1030)?
Weekly Report · 11/02 10:34
More
About VCRE
Vicore Pharma Holding AB is a Sweden-based drug-development company. The Company's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The Company is a wholly owned subsidiary of Mintage Scientific AB.

Webull offers Vicore Pharma Holding AB stock information, including NASDAQ: VCRE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCRE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCRE stock methods without spending real money on the virtual paper trading platform.